Gsa Capital Partners LLP Nuvasive Inc Transaction History

Gsa Capital Partners LLP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$47.19 - $62.68 $172,526 - $229,158	-3,656 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$56.91 - $67.81 $208,062 - $247,913	3,656 New	3,656 $219,000
Q2 2020 Aug 11, 2020	SELL	$43.51 - $66.59 $270,849 - $414,522	-6,225 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$32.82 - $81.13 $241,981 - $598,171	-7,373 Reduced 54.22%	6,225 $315,000
Q4 2019 Feb 12, 2020	BUY	$60.96 - $77.7 $828,934 - $1.06 Million	13,598 New	13,598 $1.05 Million

Q3 2019 Nov 12, 2019	SELL	$55.78 - $68.08 $798,546 - $974,633	-14,316 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$53.69 - $65.47 $73,555 - $89,693	-1,370 Reduced 8.73%	14,316 $838,000
Q1 2019 May 15, 2019	SELL	$44.53 - $58.9 $402,061 - $531,808	-9,029 Reduced 36.53%	15,686 $891,000
Q4 2018 Feb 12, 2019	BUY	$47.64 - $71.26 $1.04 Million - $1.55 Million	21,773 Added 740.07%	24,715 $1.23 Million
Q3 2018 Nov 13, 2018	BUY	$52.03 - $71.41 $153,072 - $210,088	2,942 New	2,942 $209,000
Q4 2017 Feb 14, 2018	SELL	$50.58 - $60.79 $475,603 - $571,608	-9,403 Closed	0 $0
Q3 2017 Nov 20, 2017	BUY	$53.54 - $68.0 $503,436 - $639,404	9,403	9,403 $521,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.